Year archive

Mabpharm Limited — 2024 filings

All 30 regulatory filings released by Mabpharm Limited (2181) in 2024, sourced directly from the official regulator.

30 Filings

2024 Period

2024 filings (30)

Filing	Released	Lang
INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE INDONESIAN NATIONAL AGENCY OF DRUG AND FOOD CONTROL ON THE MARKETING AUTHORIZATION OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION) Regulatory Filings	2024-12-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-03	English
CONNECTED TRANSACTIONS TERMINATION OF 2021 TENANCY AGREEMENT Regulatory Filings	2024-09-26	English
2024 Interim Report Regulatory Filings	2024-09-24	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Regulatory Filings	2024-08-28	English
DATE OF BOARD MEETING Regulatory Filings	2024-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-02	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2024-07-10	English
(1) APPOINTMENT OF NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR (2) RE-DESIGNATION OF NON-EXECUTIVE DIRECTOR AND (3) APPOINTMENT OF VICE PRESIDENTS Regulatory Filings	2024-07-10	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-03	English
INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE MINISTRY OF HEALTH OF PERU ON THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT, CMAB008 (INFLIXIMAB FOR INJECTION) Regulatory Filings	2024-07-02	English
INSIDE INFORMATION ANNOUNCEMENT APPROVAL FROM THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ON THE NEW DRUG APPLICATION (NDA) OF OUR CORE PRODUCT, CMAB009 (CETUXIMAB BETA INJECTION) Regulatory Filings	2024-06-25	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, 21 JUNE 2024 Regulatory Filings	2024-06-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 21, 2024 Regulatory Filings	2024-04-18	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-04-18	English
PROPOSED RE-ELECTION OF DIRECTORS AND PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES AND PROPOSED RE-APPOINTMENT OF AUDITOR AND NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2024-04-18	English
2023 Annual Report Regulatory Filings	2024-04-18	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Regulatory Filings	2024-04-08	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 Regulatory Filings	2024-03-26	English
DATE OF BOARD MEETING Regulatory Filings	2024-03-13	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-05	English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-23	English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-02-23	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-03	English

Filings by year

2026 14 filings
2025 27 filings
2024 30 filings
2023 29 filings
2022 30 filings
2021 34 filings
2020 30 filings
2019 27 filings